CALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCRγδ lineage

Blood

Volumn 102, Issue 3, 2003, Pages 1000-1006

  Asnafi, Vahid ^b   Radford Weiss, Isabelle ^b   Dastugue, Nicole ^b   Bayle, Chantal ^b   Leboeuf, Daniel ^b   Charrin, Christiane ^b   Garand, Richard ^b   Lafage Pochitaloff, Marina ^b   Delabesse, Eric ^b   Buzyn, Agnès ^b   Troussard, Xavier ^b   Macintyre, Elizabeth ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD2 ANTIGEN; CD5 ANTIGEN; HYBRID PROTEIN; PROTEIN CALM AF10; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER SCREENING; CELL LINEAGE; CELL MATURATION; CELL SPECIFICITY; CHILD; CHROMOSOME TRANSLOCATION 10; CHROMOSOME TRANSLOCATION 11; CLINICAL TRIAL; CYTOGENETICS; CYTOPLASM; DISEASE ASSOCIATION; EARLY DIAGNOSIS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE FUSION; GENE REARRANGEMENT; GENETIC RECOMBINATION; HUMAN; HUMAN CELL; IMMUNOGLOBULIN VDJ REARRANGEMENT; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MOLECULAR GENETICS; MULTICENTER STUDY; NUCLEOTIDE SEQUENCE; OLIGOMERIZATION; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE RECEPTOR GENE; TRANSCRIPTION REGULATION;

EID: 0041743184     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-09-2913     Document Type: Article

References (48)

1. Schneider NR, Carroll AJ, Shuster JJ, et al. New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: a pediatric oncology group report of 343 cases. Blood. 2000;96:2543-2549.
2. Hayette S, Tigaud I, Maguer-Satta V, et al. Recurrent involvement of the MLL gene in adult T-lineage acute lymphoblastic leukemia. Blood. 2002;99:4647-4649.
3. Dreyling MH, Schrader K, Fonatsch C, et al. MLL and CALM are fused to AF10 in morphologically distinct subsets of acute leukemia with translocation t(10;11): both rearrangements are associated with a poor prognosis. Blood. 1998;91:4662-4667.
4. Dreyling MH, Martinez-Climent JA, Zheng M, Mao J, Rowley JD, Bohlander SK. The t(10;11)(p13;q14) in the U937 cell line results in the fusion of the AF10 gene and CALM, encoding a new member of the AP-3 clathrin assembly protein family. Proc Natl Acad Sci U S A. 1996;93:4804-4809.
5. Groupe Francais de Cytogenetique Hematologique (GFCH). t(10;11)(p13-14;q14-21): a new recurrent translocation in T-cell acute lymphoblastic leukemias. Genes Chromosomes Cancer. 1991;3:411-415.
6. Groupe Francais de Cytogenetique Hematologique. Collaborative study of karyotypes in childhood acute lymphoblastic leukemias. Leukemia. 1993;7:10-19.
7. Kobayashi H, Thirman MJ, Rowley JD. U937 cell line has a t(10;11)(p13-14;q14-21) rather than a deletion of 11q. Genes Chromosomes Cancer. 1995;13:217-218
8. Kumon K, Kobayashi H, Maseki N, et al. Mixed-lineage leukemia with t(10;11)(p13;q21): an analysis of AF10-CALM and CALM-AF10 fusion mRNAs and clinical features. Genes Chromosomes Cancer. 1999;25:33-39.
9. Carlson KM, Vignon C, Bohlander S, Martinez-Climent JA, Le Beau MM, Rowley JD. Identification and molecular characterization of CALM/AF10 fusion products in T cell acute lymphoblastic leukemia and acute myeloid leukemia. Leukemia. 2000;14:100-104.
10. Bohlander SK, Muschinsky V, Schrader K, et al. Molecular analysis of the CALM/AF10 fusion: identical rearrangements in acute myeloid leukemia, acute lymphoblastic leukemia and malignant lymphoma patients. Leukemia. 2000;14:93-99.
11. Jones LK, Chaplin T, Shankar A, et al. Identification and molecular characterisation of a CALM-AF10 fusion in acute megakaryoblastic leukaemia. Leukemia. 2001;15:910-914.
12. Salmon-Nguyen F, Busson M, Daniel M, Leblanc T, Bernard OA, Berger R. CALM-AF10 fusion gene in leukemias: simple and inversion-associated translocation (10;11). Cancer Genet Cytogenet. 2000;122:137-140.
13. Narita M, Shimizu K, Hayashi Y, et al. Consistent detection of CALM-AF10 chimaeric transcripts in haematological malignancies with t(10;11)(p13; q14) and identification of novel transcripts. Br J Haematol. 1999;105:928-937.
14. Breit TM, Wolvers-Tettero IL, van Dongen JJ. Phenotypic and genotypic characteristics of human early T-cell differentiation: the T-cell acute lymphoblastic leukaemia model. Res Immunol. 1994;145:139-143; discussion 155-138.
15. Gomez E, San Miguel JF, Gonzalez M, et al. Heterogeneity of T cell lymphoblastic leukaemias. J Clin Pathol. 1991;44:628-631.
16. Asnafi VBK, Boulanger E, Comba B, et al. Analysis of TCR, pT(alpha) and RAG-1 in T acute lymphoblastic leukemias improve understanding of early human T lymphoid lineage commitment. Blood. 2002;101:2693-2703.
17. + progenitors capable of developing into T cells are not committed to the T cell lineage. J Immunol. 1997;158:3571-3577.
18. Blom B, Verschuren MC, Heemskerk MH, et al. TCR gene rearrangements and expression of the pre-T cell receptor complex during human T-cell differentiation. Blood. 1999;93:3033-3043.
19. Lauzurica P, Krangel MS. Enhancer-dependent and -independent steps in the rearrangement of a human T cell receptor delta transgene. J Exp Med. 1994;179:43-55.
20. Spits H, Blom B, Jaleco AC, et al. Early stages in the development of human T, natural killer and thymic dendritic cells. Immunol Rev. 1998;165:75-86.
21. Mitelman F. ISCN: An International Systeme for Human Cytogenetic Nomenclature. Basel, Switzerland: Kerger; 1995.
22. Romana SP, Le Coniat M, Berger R. t(12;21): a new recurrent translocation in acute lymphoblastic leukemia. Genes Chromosomes Cancer. 1994;9:186-191.
23. Res P, Spits H. Developmental stages in the human thymus. Semin Immunol. 1999;11:39-46.
24. + acute lymphoblastic leukemias. Nouv Rev Fr Hematol. 1990;32:95-99.
25. Langerak AW, Wolvers-Tettero IL, van den Beemd MW, et al. Immunophenotypic and immunogenotypic characteristics of TCRgammadelta+ T cell acute lymphoblastic leukemia. Leukemia. 1999;13:206-214.
26. Hayday AC. γδ cells: a right time and a right place for a conserved third way of protection. Annu Rev Immunol. 2000;18:975-1026.
27. Machugh ND, Mburu JK, Carol MJ, Wyatt CR, Orden JA, Davis WC. Identification of two distinct subsets of bovine gamma delta T cells with unique cell surface phenotype and tissue distribution. Immunology. 1997;92:340-345.
28. Moingeon P, Chang HC, Wallner BP, Stebbins C, Frey AZ, Reinherz EL. CD2-mediated adhesion facilitates T lymphocyte antigen recognition function. Nature. 1989;339:312-314.
29. Sasada T, Reinherz EL. A critical role for CD2 in both thymic selection events and mature T cell function. J Immunol. 2001;166:2394-2403.
30. Davis SJ, van der Merwe PA. The structure and ligand interactions of CD2: implications for T-cell function. Immunol Today. 1996;17:177-187.
31. Boeckx N, Willemse MJ, Szczepanski T, et al. Fusion gene transcripts and Ig/TCR gene rearrangements are complementary but infrequent targets for PCR-based detection of minimal residual disease in acute myeloid leukemia. Leukemia. 2002;16:368-375.
32. Kimura N, Akiyoshi T, Uchida T, et al. High prevalence of T cell receptor D delta 2(D delta)J delta rearrangement in CD7-positive early T cell acute lymphoblastic leukemia. Leukemia. 1996;10:650-657.
33. Groeneveld K, te Marvelde JG, van den Beemd MW, Hooijkaas H, van Dongen JJ. Flow cytometric detection of intracellular antigens for immunophenotyping of normal and malignant leukocytes. Leukemia. 1996;10:1383-1389.
34. dim cells in the human thymus can differentiate into T, natural killer, and dendritic cells but are distinct from pluripotent stem cells. Blood. 1996;87:5196-5206.
35. King AG, Kondo M, Scherer DC, Weissman IL. Lineage infidelity in myeloid cells with TCR gene rearrangement: a latent developmental potential of proT cells revealed by ectopic cytokine receptor signaling. Proc Natl Acad Sci U S A. 2002;99:4508-4513.
36. + lymphocyte populations with different T cell receptors: a role for the gut epithelium in T cell differentiation. J Exp Med. 1991;173:471-481.
37. Bandeira A, Mota-Santos T, Itohara S, et al. Localization of gamma/delta T cells to the intestinal epithelium is independent of normal microbial colonization. J Exp Med. 1990;172:239-244.
38. Chaplin T, Ayton P, Bernard OA, et al. A novel class of zinc finger/leucine zipper genes identified from the molecular cloning of the t(10;11) translocation in acute leukemia. Blood. 1995;85:1435-1441.
39. Linder B, Newman R, Jones LK, et al. Biochemical analyses of the AF10 protein: the extended LAP/PHD-finger mediates oligomerisation. J Mol Biol. 2000;299:369-378.
40. Saha V, Chaplin T, Gregorini A, Ayton P, Young BD. The leukemia-associated-protein (LAP) domain, a cysteine-rich motif, is present in a wide range of proteins, including MLL, AF10, and MLLT6 proteins. Proc Natl Acad Sci U S A. 1995;92:9737-9741.
41. Ayton PM, Cleary ML. Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins. Oncogene. 2001;20:5695-5707.
42. DiMartino JF, Ayton PM, Chen EH, Naftzger CC, Young BD, Cleary ML. The AF 10 leucine zipper is required for leukemic transformation of myeloid progenitors by MLL-AF10. Blood. 2002;99:3780-3785.
43. Clarkson BD, Strife A, Wisniewski D, Lambek C, Carpino N. New understanding of the pathogenesis of CML: a prototype of early neoplasia. Leukemia. 1997;11:1404-1428.
44. Kabarowski JH, Witte ON. Consequences of BCR-ABL expression within the hematopoietic stem cell in chronic myeloid leukemia. Stem Cells. 2000;18:399-408.
45. Wong S, Witte ON. Modeling Philadelphia chromosome positive leukemias. Oncogene. 2001;20:5644-5659.
46. Tebar F, Bohlander SK, Sorkin A. Clathrin assembly lymphoid myeloid leukemia (CALM) protein: localization in endocytic-coated pits, interactions with clathrin, and the impact of overexpression on clathrin-mediated traffic. Mol Biol Cell. 1999;10:2687-2702.
47. Linder B, Jones LK, Chaplin T, et al. Expression pattern and cellular distribution of the murine homologue of AF10. Biochim Biophys Acta. 1998;1443:285-296.
48. Silliman CC, McGavran L, Wei Q, Miller LA, Li S, Hunger SP. Alternative splicing in wild-type AF10 and CALM cDNAs and in AF10-CALM and CALM-AF10 fusion cDNAs produced by the t(10;11)(p13-14;q14-q21) suggests a potential role for truncated AF10 polypeptides. Leukemia. 1998;12:1404-1410.